2012 Scrip 100: Asia grows drug discovery footprint
This article was originally published in Scrip
The dramatic rise of clinical trial outsourcing over the past decade has been widely heralded. Although less frequently discussed, it is no less significant that pharma companies are increasingly farming out a wide variety of drug discovery processes to third-party providers. George Green looks at the market for outsourcing, with a special eye on China.